• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

WHO asks India to conduct nationwide study on MDR-TB

Shiloh

Editor, Senior Moderator
Source: http://timesofindia.indiatimes.com/...wide-study-on-MDR-TB/articleshow/11772699.cms

WHO asks India to conduct nationwide study on MDR-TB
The writer has posted comments on this articleKounteya SinhaKounteya Sinha, TNN | Feb 6, 2012, 04.03AM IST

NEW DELHI: Multi drug resistant tuberculosis (MDR-TB) is spreading far and wide across the globe. The latest World Health Organisation (WHO) analysis published on Saturday said cases of MDR-TB had now been reported from 80 countries, in some instances in almost 30% of all newly diagnosed cases.

But only 34 countries have a system in place to routinely test all patients with MDR-TB for second line anti-TB drug resistance. The global overview also shows record levels of this serious public health threat, with some countries reporting MDR-TB in more than 65% of patients who have been previously treated for TB.

However, WHO rued the fact that India, which has a major burden of MDR-TB, still does not have national level data on this serious air-borne disease. It said, "Whereas China has been able to conduct a nationwide survey, India and the Russian Federation - the other two large countries that, with China, contribute to more than 50% of the estimated global burden of MDR-TB -- have only produced reliable sub-national level data to date. To understand the magnitude of the MDR-TB problem and address it, nationwide surveillance systems should be established in all countries, with greater urgency in the highest burden settings."

Dr Matteo Zignol from the Stop TB Department at WHO said, "Surveillance of resistance to drugs is the cornerstone of TB control. Following 15 years of intensive effort, we now have high quality data for two-thirds of countries in the world. At the same time, we don't know the full extent of the problem because we lack data from many countries, in particular India and most of Africa where the TB burden is high."...
 
Back
Top Bottom